Pfizer plans to cut price for Prevnar 13 in poor countries; Allergan schedules shareholder meeting to approve Actavis buy;

@FiercePharma: Supreme Court pitches patent fight over $SHPG's Lialda after $TEVA ruling. Report | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Actavis explains the recall of generic Neurontin was limited to 2,000 bottles shipped to one customer. Story | Follow @EricPFierce

> Pfizer ($PFE) is cutting the price for its pneumococcal vaccine Prevnar 13 by 6% in developing countries as part of its commitment to a global vaccines alliance. Story

> Allergan ($AGN) scheduled a March 10 meeting to get shareholder approval for its purchase of Actavis ($ACT). Article

> Bayer struck a licensing and distribution deal with Hungarian drugmaker Richter to sell the company's contraceptive patch in Europe. More

> Sen. Elizabeth Warren (D-MA) proposed funding initiatives through the National Institutes of Health (NIH) by fining Big Pharma companies for illegal practices. Story

> Oklahoma is asking the U.S. Supreme Court to delay the execution of three death-row inmates as it tries to obtain a different sedative for lethal injections. More

Medical Device News

@FierceMedDev: Sequenom strikes a deal with Cypher Genomics to develop advanced noninvasive prenatal test. FierceDiagnostics story | Follow @FierceMedDev

@EmilyWFierce: IYCMI yesterday: Medtronic and Covidien to close $43B merger today with Irish High Court approval. Article | Follow @EmilyWFierce

> Medtronic sets sights on hospital and product innovation post-Covidien deal close. News

> Hoffman pleads guilty to murdering former Boston Sci exec in Minneapolis suburb. Report

> J&J launches new, smaller, more precise vascular stapler for thoracic surgery. Article

Biotech News

@FierceBiotech: The Special K connection: Naurex spotlights another promising NMDA depression drug. Report | Follow @FierceBiotech

@JohnCFierce: I see R&D costs climbed to $7.1B at $PFE last year. Probably same again in '15. Citing Phase III costs. Release | Follow @JohnCFierce

@DamianFierce: Per earnings statement, $NVS finally submitted the COPD combo QVA149 + NVA237 to the FDA late last year. Release | Follow @DamianFierce

> Google, Biogen team up on MS research: report. Item

> Obama wants to pour $1.2B into antibiotic R&D. Report

> Singapore's MerLion eyes partner for Phase III of Finafloxacin urinary infection trials. Article

Biotech Research News

> UCSD team turns the PKC tumor theory upside down. Item

> Psoriasis researchers identify a lineup of suspect proteins behind disease progression. More

> International team tags a key brain pathway for hypoglycemia. Report

> Stanford scientists use modified RNA to rejuvenate aging cells. Story

> Alzheimer's investigators at Gladstone find a drug target for guarding memories. Article

Pharma Manufacturing News

> BASF invests $63M in PVP manufacturing operations. More

> Novo will soon open plant in Russia. Article

> Hospira recalls more saline after human hair found in a bag. Report

> FDA slaps down another Indian plant, adding to the industry's woes. Story

> Australia's TGA issues updated guidelines on drug supply chain releases. Item

And Finally… A new study found that the longer people have high cholesterol, the greater their risk for developing heart disease. Story (sub. req.)

Suggested Articles

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.

Alexion and Amgen reached a deal to put off a biosimilar challenger to Alexion's blockbuster rare disease med Soliris until March 2025.

A top adviser for the Trump administration is calling on Congress to push for more manufacturing in Puerto Rico.